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Fluorescence quenching has been used to study the interactions of daunomy
cin and myricetin with various quenchers — adenosine triphosphate (ATP), L-
tryptophyl-L-tryptophan, L-tryptophyl-L-tryosine myosin, and deoxyribonucleic
acid (DNA), at various pH levels. DNA, although producing a quenching effect on
the fluorescence of daunomycin, enhanced the fluorescence of myricetin. Fluore
scence quenching has also been used to study the interactions of DNA in the
presence and absence of divalent metal ions, with daunomycin. The values of the
Stern-Volmer quenching constant (ksy), and static quenching constants (V) obtained,
indicate that the quenching of daunomycin and myricetin fluorescence by the
quenchers studied proceed via collisional, static, as well as, selective quenching
mechanisms, and that they are good quenchers for daunomycin fluorescence. The
IX
studies also revealed the pH-dependence of daunomycin fluorescence quenching.
Physiologically high levels of Fe++, Cu++, and Mg++, increased the apparent
association contant (K ) for daunomycin-DNA complex, and changed the number
app
of available binding sites per drug molecule. The addition of Fe+ , Mg and Cu+
did not produce any change in the binding site model of daunomycin-DNA.
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INTRODUCTION
Daunomycin (Fig. 1), is an anthracycline antibiotic isolated from strepto-
myces peucetius, which possesses antitumor activity against certain animal and
human neoplasms. " Due to its clinical value in cancer chemotherapy, extensive
studies have been devoted to elucidating the mechanism of action of the drug in the
hope of improving its chemotherapeutic index and eliminating its cytotoxic effect.
2 6 7
The accumulated evidence suggests that this drug binds to the cell genome ' '
6 8-13
and perturbs cellular DNA and ribonucleic acid (RNA) synthesis. ' ~ It remains
uncertain, however, whether the antimitotic activity of daunomycin arises
exclusively from interactions with DNA and inhibition of nucleic acid synthesis.
Indeed, studies with synchronized cell cultures have shown that the antimitotic
1112
effect of daunomycin may occur at different phases of the cell cycle ' and at
daunomycin concentrations which do not affect DNA synthesis. N-acetyl-
daunomycin, while possessing only a weak effect on nucleic acid synthesis, is
capable of inhibiting cell mitosis. Furthermore, cross resistance of cells has been
observed toward daunomycin and vinca alkaloids, a class of potent antimitotic
drugs known to act through binding to microtubule protein with ensuing spindle
poisoning. The last observation suggests the possible existence of a common site of
interaction between these two different kinds of antimitotic drugs. It has in fact
been speculated that the mechanism of the antimitotic effect of daunomycin could
involve the perturbation of spindle fibre function.
The possibility of the existence of a common site of interaction between
daunomycin and vinca alkaloids is of special interest. To pursue deeper into this
expressed interest, myricetin (3,3',4',5,5',7-hexa hydroxyflavone), (Fig. 2), has been
1






Fig. 2. Structure of myricetin.
selected as a model for comparative studies. Daunomycin binds to nucleic acids by
intercalation, as well as by electrostatic binding. Two major requirements for
these modes of binding is that the drug molecule exhibits planarity and aromati-
city, characteristic features shared by both daunomycin and myricetin. Also, it
has been recently observed that myricetin inhibits glycolysis in tumor cells when
the mitochondrial ATPase supplied Pidnorganic phosphate) and adenosine diphos-
phate. This mitochondrial ATPase inhibition by myricetin is also exhibited by'
daunomycin, a possible means by which the energy necessary for RNA-based
DNA synthesis is depleted. Although daunomycin and myricetin share similar
characteristic features and effects, it remains uncertain whether the two
antimitotic drugs would in fact affect similar biomolecules in the same manner,
and, to the same degree.
Interaction of daunomycin with actin and myosin (muscle components) has
been studied.18 Heavy meromyosin exhibited an emission Xmax at 350 nm when
excited at \ of 300 nm. The emission wavelength of 350 nm is due to the trypto-
phanyl and/or the tyrosine residues of the proteins. Even though it has been
substantiated that daunomycin quenches the fluorescence of the tryptophan and
tyrosine moieties of several biopolymers the exact nature of the interaction is not
known. Model studies with the dipeptide of tryptophan or tryptophan-tyrosine may
be helpful in this regard. Elucidating the interaction of myricetin with either of
the two dipeptides, will also be appropriate.
The clinical use of daunomycin, as mentioned earlier, has been limited due to
its cardiotoxicity. The intense efforts to date to ameliorate this cardiotoxicity
involve, in addition to a search for less cardiotoxic derivatives, antagonists of the
cardiotoxicity; on the other hand, understanding the mechanism of action of the
drug would help in design of strategies to alleviate this problem.
Physiological levels of certain divalent metal ions have shown interesting
interactions with daunomycin, and daunomycin-deoxyribonucleic acid complexes. '
The exact trends of the effects of these divalent metal ions on daunomycin-
deoxyribonucleic acid complexes, with a major interest on how the association
constants of the complex vary—a factor which could possibly be related to the
residency time of the drug in the tissue—and, a general interest on the variation of
the number of binding sites available—a factor which could throw some insight into
the drug-metal ion-DNA complex-remains to be determined. In order to assess
these interactions of daunomycin with various cellular components (the major
thrust of this thesis), studies have been undertaken using fluorescence methods.
Fluorescence Phenomena. The principles of fluorescence spectroscopy are
by now well established, and after a rather lengthy gestation period, the technique
is now routinely applied to a broad spectrum of problems, ranging from mechanistic
photochemistry to chemical analysis in biomedical and environmental systems, to
probes of structure, function, and complexations in biological macromolecules.
When a ray of polarized light passes through a solution medium of thickness,
I, which contains an absorbing species at a concentration, c, the loss of intensity is
proportional to the thickness, the concentration, and the intensity of the incident
19
light. This process is summed up in the Beer-Lambert Law which is represented
by:
If = I.exp(-acO (1)
where I. is the intensity after the medium, I. is the intensity before passing through
the medium, is the absorption coefficient which depends both on the molecule
under study and the frequency of the light, c is the concentration of the solution,
and A is the thickness of the sample. The loss of intensity is due to the loss of
energy to some of the chromophores (in the solution) which now go from their
ground states to their excited states. These excited molecules will eventually
return to the ground state through loss of the absorbed energy by one of several
ways, including a slow loss of energy by emission of light which forms the
fundamental basis for fluorescence spectroscopy.
Type of Probe. Since a probe of a biological system is considered to be a
molecule, small relative to that system, and providing information about the
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limited volume in which it is found, fluorescent probes are therefore able to
reflect their environments by the emission they produce upon excitation.
Throughout this research, concentration is focused on the role played by intrinsic
probes?0 i.e., molecules which are already fluorescent. The Xmax for such
molecules in the visible or ultraviolet region of the electromagnetic radiation gives
an absolute indication of the wavelength at which the excitation wavelength should
be set.
At a given excitation wavelength, temperature and pH, a given chromophore
will exhibit a spectrum which is directly proportional to the intensity of energy
absorbed. Upon interaction with molecules other than those present in the homo
geneous solutions, a spectrum which is different from the natural spectrum is
observed. The new spectrum may depict lower intensity (quenching) or a higher
intensity (enhancement). A change in intensity is therefore a good indication of
molecular interaction, and forms a basis for the investigations that follow in subse
quent sections.
The Fate of an Excited Molecule, M. When a molecule, M, is excited by
absorption of energy, the excited state, M*, differs from the ground state with
respect to both energy and electronic wave function. ' During the lifetime,
, of M* several processes could occur—dissipation of the excitation energy, wholly
or partly, by thermal collisional processes, e.g., radiationless return to the ground
state, or decomposition of the molecule, or a chemical reaction (the excited state
is more reactive), or formation of a complex (with ground state of same species,
excimer, or another species, exciplex), or ionization of the molecule, or, during the
transition from the excited singlet to the ground state, the energy may be emitted
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as light, a phenomenon known as fluorescence. ' ' Also possible is the
occurence of intersystem crossing—the molecule crossing over to one of the
vibrational levels of a triplet state. This process competes with fluorescence, and
when it occurs, the radiative transition from the lowest triplet state to the ground
21
state is known as phosphorescence (Fig. 3).
Although the excited state is in general more reactive than the ground state,
a reaction can be observed by fluorescence measurements only if the reaction time
is comparable to or shorter than the mean life-time of the unperturbed excited
state. Quenching of fluorescence and complex formation are two such reactions
22
that satisfy this kinetic requirement.
vc
Fjr. 3. Modified Jablonski diagram showing transitions between excited states and the ground state. Radiative
processes are shown by straight lines; raditionless processes by wavy lines. ISC = intersystem crossing; IC =
internal conversion; vc = vibrational cascade; hY, = fluorescence; Ivf = phosphorescence. *From Ref. 21.
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Fluorescence Quenching. Quenching is essentially a decrease in fluorescence
intensity of a fluorophor via "physical contact" of the fluorophor with a quencher,
Q. A number of important processes come under the general heading of
"quenching." They have often been divided into viscosity-dependent (dynamic) and
viscosity-independent (static) types.
All quenching processes can be considered as bimolecular processes in
competition with the emission, internal conversion, and intersystem crossing
phenomena from the first excited singlet state of the fluorophore. Five types can
be distinquished: collision quenching (diffusion controlled), collision quenching
(non-diffusion controlled), energy transfer quenching, concentration quenching
(excimer formation), and radiative migration (self-absorption). Radiative
migration is a property of the bulk solution, and since its effect is not a source of
much information, normally it is to be avoided. Concentration quenching, on the
other hand, is potentially a very useful indicator of local fluorophore concentra
tions. The effect is caused by association of an excited fluorophore with a
ground-state fluorophore to yield an excited state dimer (excimer) with altered
fluoroscence properties.
k.
M + M* — y (M ... M)* (2)
The concentration-quenching process is conveniently described in terms of the
concentration, c^, of M needed for 50% decrease in the fluorescence yield of M*.
In liquid solution, the process is diffusion controlled, hence,
dm
where $ ° and $ are, respectively, the fluoroscence quantum yield for M* in the
absence of and presence of quenching by ground-state, M. Pyrene derivatives
constitute the classical example of fluorescence quenching via excimer
formation.
Energy-transfer quenching can occur over much greater distance than "colli-
sional" quenching. It involves a resonance between the transition dipoles. It
depends on the relative orientation of the two molecules, the degree of overlap of
the emission band of a sensitizer and the absorption band of the emitter and the
molecules.2 The transfer is thus possible over distances of the order of 50 R.
Since the two reactants, M or M* and Q in solution would be required to form an
encounter complex, they must approach to a distance within 50 A, where any kind
of interaction may become significant for quenching of fluorescence to take
place.
The encounter complex, (M* ... Q), arises via the two modes of collisional
quenching mentioned above, diffusion controlled and non-diffusion controlled
(static) as shown below:
kd
Diffusional M* + Q ^ (M*... Q)
hv
Static M + Q >- (M ... Q)
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(M* ... Q) is formed with a diffusion-controlled rate constant, k ., and the reaction
completes the quenching of the fluorescence with a reaction constant, k~
k2
(M* ... Q) ► M + Q + hv (5)
The observed rate constant for this quenching, k-, is equal to a k ., where a is the
22
efficiency of the quenching process. If the efficiency is less than one, k- =
22
k jkj/k . (i.e., not every encounter between M or M* and Q leads to quenching).
k1 is the formation constant for (M ... Q) and therefore viscosity independent. If k_d
23
approaches zero and (M ... Q) is non-fluorescent, then
Fq/F = (1 + k t Q [ Q ] )(1 + k' [ Q ]) (6)
where F and F are fluorescence intensities in the absence and presence of Q
o
respectively, k is apparent constant for the collisional quenching given by Eq. 4,
and t is fluorescence lifetime in the absence of a quencher, Q. Two cases of
o
interest follow from Eq. 6. First, if ground-state complex formation is negligible,
then k' = o and Eq. 6 reduces to
+ ksv^] =To* (7)
where k is equal to k t , and x equal fluorscence lifetime in the presence of a
sv ^ q o
24
quencher. This is the classical Stern-Volmer equation for diffusion controlled
11
collisional quenching. At the other extreme, if k, = 1/T , then the observed
o
quenching is entirely due to ground-state complexation and
Fq/F = 1 + k'[Q] (8)
where kgv = k1. It is seen that in both the limiting cases, the observed quenching
obeys a Stern-Volmer relation.
A plot of FQ/F vs. [ Q] would yield k T , from which k could be
determined, (if is known) and Eq. 8 predicts a linear increase in the Stern-
Volmer quenching constant, k$v, with increasing [Q] . When both processes are
operative simultaneously, plots of F /F against [ Q ] cease to be linear. Positive




According to Weller such deviations arise because the reaction time is
comparable to the time required to reach steady-state (for diffusion-controlled
reactions) and only a certain fraction, W, of the excited molecules obey the Stern-
Volmer equation. W is related to the fluorescence quantum yield, $, by
(9)
where $° and $ are the quantum yield in the absence and presence of a quencher,
and the residual fraction (1 - W) does not contribute to the fluorescence yield. W is
also related to the molar volume of diffusion by
12
W = exp(-VD[Q]) (10)
22
where V_ is the molar volume of diffusion.
To account for the excited states which are instantaneously deactivated by Q
(i.e., the residual fraction, 1 - W), the Stern-Volmer equation is modified as:
FQ/F1 = (1 + ksv[Q])exp(V[Q]) (11)
or
Fo/FexpV[Q] = 1 + ksy[Q] = °/T (12)
where V is the static quenching constant and describes the quenching of M by Q
which is randomly positioned in the vicinity of M at the time M is excited. The
positive deviation from the classical Stern-Volmer plot is attributed to static
22
quenching.
In this thesis, the interaction of daunomycin with adenosine triphosphate, L-
tryptophyl-L-tryptophane, L-tryptophan-L-tyrosine, and the interactions of
myricetin with L-tryptophyl-L-tryptophan, as well as the interactions of both
molecules with deoxyribonucleic acid and myosin will be discussed. Also the results
of the effects of some divalent metal ions—Fe++, Cu++, Mg++—upon the interaction
of daunomycin with deoxyribonucleic acid will be presented.
EXPERIMENTAL
Materials. Daunomycin (Dm), myricetin (3,3',4'5,5',7-hexahydroxyflavone)
crystals, adenosin triphosphate (ATP), L-tryptophyl-L-tryptophan, L-tryptophyl-L-
tyrosine, and CuSCX" 5 FUO were obtained from Sigma Chemical Company, St.
Louis, Missouri. Calf thymus DNA was a generous gift from Dr. David Wilson of
Georgia State University, Atlanta, Georgia. Anhydrous piperazine was purchased
from Aldrich Chemical Company. NaCl, and MgCl2*6 H2O were obtained from 3.
T. Baker Chemical Company. All the commercially obtained chemicals were used
without further purification.
ATP samples were made by dissolving in Tris buffer; L-tryptophyl-L-
tryptophan, and L-tryptophyl-L-tyrosine samples were made by dissolution in 50:50
(v/v), water-ethanol mixture, and stirred for three hours at room temperature.
Daunomycin sample was prepared in piperazine buffer, and its concentration was
determined spectroscopicaliy employing a Varian Cary 210 from its known
extinction coefficient of 11,500 M cm at 480 nm. Myricetin samples were
prepared by dissolution in 50:50 (v/v) water-ethanol mixture, and the resulting
mixture stirred for 30 minutes at room temperature. Solutions of CuSO^, MgCl2,
and FeCl2 were prepared by dissolving the solids in deionized water, and diluting to
concentrations of interest. In making the buffer, 0.01 M piperazine and 0.1 M NaCl
were diluted in deionized H2O, and pH was adjusted with HC1.
Fluorescence Intensity Measurements. Fluorescence intensity measurements
at ambient temperatures were made on a Perkin-Elmer MPF-44A fluorescence
spectrophotometer, equipped with a magnetic stabilizer for Xenon arc light source,
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differential corrected spectra unit, a model 2000 X-Y recorder, and temperature
controls. Intensity of the lamp was found to be extremely stable over the time
course of the quenching experiments. Band widths of 10 mm were routinely used.
In every study pursued involving ATP, L-tryptophyl-L-tryptophan, L-tryptophyl-L-
tyrosine, and DNA, the shape and position of the emission spectrum of (Dm) was
not noticeably changed. The intensity of the emission maximum at 592 nm was
therefore monitored in the quenching studies. Optical density measurements were
made on a Varian Cary 210 spectrophotometer.
The quenching experiments were performed by using a couple of different
routines, both giving similar results. In one, the fluorescence of different samples
of daunomycin of the same concentration, and a graduated amount of quencher,
was measured. However, as a matter of mere convenience and for purposes of
monitoring the stability of the complexes formed, small aliquots (ranges: 0.5 -
20\ii) of quencher solutions were added to series of sample solutions, using a
Rainin 20 yfc 1 micropipette, in a 3 ml teflon fluoremetric cuvette, having an
insignificant optical density at the excitation wavelengths of interest. After each
addition, the solution was gently agitated by inversion, and air bubbles removed by
bubbling nitrogen through the sample, before fluorescence intensity was measured.
For the daunomycin fluorescence quenching, fluorescence measurements were
made at excitation wavelengths of 300 nm and 466 nm. Fluorescence quenching
measurements for the myricetin quenching were made at excitation wavelength of
375 nm. pH was varied by using different buffer solutions.
Scatchard Analyses. The quenching experiment of daunomycin vs. DNA was
performed by progressive additions of small aliquots (ranges 0.5 to 2\il ) of DNA
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stock solutions. The quenching experiments of Dm + M + vs DNA were performed
by initial addition of M + to Dm after scanning Dm alone, followed by subsequent
and progressive additions of small aliquots of DNA as outlined above. Each cuvette
contained 3.33 nm drug in 3 ml of solution, and DNA concentration varied such
that [DNA] / [Dm ] ratio varied from 0 to 8. The [DNA] / [Drug] ratio of 8 was
taken as the end point in this titration, with the drug considered to be maximally
bound, based on the observation that the fluorescence intensity reached a plateau
at this point. The concentrations of the divalent metal ions—Fe++, Cu , Mg was
always 3.33 vM such that [Drug] / [M +] = 1, throughout the experiment.
The binding data were analyzed by the Scatchard method. The Scatchard
variables r. (moles of ligand bound per nucleotide) and c (the molar concentration
of free ligand) were calculated from the fluorescence data according to the method
of Peacoke and Skerrett. Binding -parameters were determined from plots of rb
vs r./c, in which K (apparent association constant) is the negative slope and
— b app
n (the apparent number of binding sites per nucleotide) is the x-intercept.
app
To obtain the Scatchard variables, rfa and rb/C (C = free drug concentration)
were necessary, and they were calculated as discussed below. When a spectrum of
the drug (daunomycin) in the absence of a quencher, Q, is scanned, the fluorescence
intensity of emission at Xmav is recorded as F . A spectrum of the drug in the
presence of the quencher is then scanned, with the fluorescence intensity recorded
this time as F. Subsequent scans at higher Q concentration, with, of course, more
reduced intensities of fluorescence, F, are recorded. In this study, ten scans were
made for each experiment. The concentration of bound drug, Cb, is given by:
Cb = FbXCT,
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where F. and CT are fraction of drug bound and total concentrations of drug
respectively. The fraction of bound drug, F., is given by:
Fo-F
where F and F are fluorescence intensities in the absence and presence of a
quencher respectively, and F „ is the fluorescence intensity when the drug is
assumed to be maximally bound, and this is taken from the plateau region of the
plot of intensity vs. quencher concentration (vide intra). The free drug
concentration, C, is therefore given by:
c = cT -cb
rb is given by
rb •
[Q]
where [Q ] is the concentration of the quencher, DNA. A plot of rb/C vs. rb
(Scatchard plot) is expected to give a linear curve, but concave, or even, convex
curves have been observed. If a linear curve obtains, the negative slope of the
curve gives K (apparent association constant), and the intercept on the x-axis
givens n (apparent number of binding sites per nucelotide). If a deviation from
app
linearity obtains, the slopes of the two tangents which intercept at the the point of
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curvature give the respective K^'s (two apparent associations constants K , and
app
K j now exist). If K .- K -is insignificant, a single K is chosen. On the
app app app app
other hand, if K j- K ^ iS a large value, the different K 's are determined,
app app pp
For relative fluorescence studies, the fluorescence intensity, F , in the
absence of a quencher, Q, was taken as a 100% fluorescence, 0% fluorescence was
recorded when the drug was totally bound, in the plateau region of the spectra.
Determination of k and V. All the analyses were made on a Tektronix
terminal of the Prophet system. The Stern-Volmer and the modified Stern-Volmer
equations were analyzed using an in-fitted fit function program. In this program,
the classical Stern-Volmer equation:
FQ/F = 1 ♦ ksy [Q] ,
is replaced by the function:
(1 + BjX),
where B. now stands for k , and X represents [Q ], the quencher concentration.
X SV
In the same manner, the modified Stern-Volmer equation:
FQ/F = (1 + ksv [Q])exp(V[Q]),
now becomes
(1 + Bjx) exp (B2x),
18
where b~ now stands for V, the static quenching constant. In accordance with the
Stern-Volmer prediciton, a plot of Fq/F vs. [Q ] would give a linear curve from Eq.
8, the slope of which is Bp or k . The value of B2 or V is also given by the
computer. Also, when the function is changed to (1 + Bjx) exp(B2x), a linear plot is
obtained from Eq. 11 and this represents the modified Stern-Volmer plot.
Fluorescence Enhancement Studies. Enhancement studies were performed
following basically the same procedures used in the quenching experiments (pro
gressive addition of aliquots of the quencher). The fluorescence intensity of the
drug alone was recorded as F , and subsequent intensities (enhancement) were
recorded as F after each addition of Q, respectively. A plot of 1/ AF ( aF =
F/j _/>\-Fj ) vs. 1/[Q ] would give a linear curve. By extrapolating the curve
idrug-QJ drug — ^ °
to 1/ [Q] = 0, i.e., at infinite concentration of Q, F could be calculated. Using the
26 (F - Fo>
F,,, thus obtained, a plot of log — vs. —log [Q ] would also yield a linear
(F»- F)
(F — F )




Quenching of Daunomycin Fluorescence by ATP. Figs. 4, 5, and 6 represent
the results, plotted in Stern-Volmer fashion (Eq. 8) of ATP quenching studies of
daunomycin. The amount of fluorescence observed in the presence of quencher
(ATP) was not time dependent, indicating that permanent photochemistry is not
involved, to any great extent, in the quenching process.
It is apparent, from Figs. 4, 5, and 6 that as you increase the concentration of
daunomycin from 10'7 M (Fig. 4) to 10"5 M (Fig. 6), the plot of Fq/F vs. [ Q ]
changes from a positive deviation (Fig. 4) to a negative deviation (Fig. 6), and in
fact to almost a linear curve (Fig. 5) in conformity with (Eq. 8). By treating the
data according to Eq. 11, that is, by plotting FQ/F exp(V[Q]) vs. [Q ] for varying
V until linear plot is obtained, the static and collisional quenching modes can be
dissected. From analysis of the plots (Figs. 4, 5, and 6) the following kgy and V
values were found - k = 0, V = 469.19 M"1 ( Dm = 10"7 M), k = 89.27 M"1, V
5V ^ ™
= 4.217 M'1 ( Dm = 10'5 M), and k = 182.7 M"1, V = 0 M"1 ( Dm = 10"6) . At
sv
higher k values, collisional quenching is the major mode of quenching, and static
quenching predominates at high V values. The upward curvature (Fig. 4) is similar
26-28
to those found in many other detailed quenching studies. ~ This type of
deviation from the expected linear plot can be explained by the fact that only a
certain fraction of the excited states is actually quenched by the collisional
mechanism as described by Stern and Volmer. In contrast to Fig. 4, the Fq/F vs.
[Q] plot at higher Dm concentrations (Fig. 5) shows a negative deviation from
linearity. Similar quenching patterns have also been observed. ' This deviation
19
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[ATP]
Fig. 4. Stern-Volmer plot for the ATP quenching of daunomycin, at daunomycin concentration of
1.35 x 10" M; the sample was excited at 466 nm; Fq and F are the fluorescence intensities (arbitrary
units) in the absence and presence of a quencher respectively.
2.0 t
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[ATP]
Fig. 3. Stern-Volmer plot for the ATP quenching of daunomycin, at daunomycin concentration of 1.35 x 10 Mj
the sample was excited at 466 nm; Fq and F are the fluorescence intensities (arbitrary units) in the absence and





»K» 6. Stern-Volmer plot for the selective ATP quenching of daunomycin at daunomycin concentration of 1.3 x
M; the sample was excited at 466 nm; Fq and F are the fluorescence intensities (arbitrary units) in the
absence and presence of a quencher respectively
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reflects the selectivity in quenching, and indicates that selective quenching
overwhelms any positive deviations caused by the static component.
Quenching of Daunomycin Fluorescence by L-tryptophyl-L-tryptophan.
Presented in Fig. 7 is an example of the results of L-trp-L-trp quenching of dauno
mycin plotted in Stern-Volmer and modified Stern-Volmer fashions. All the curves
show positive deviations—upward curve. This could mean that there is a very
strong contribution to quenching by static mechanisms, a fact which is very much
supported by the high V-values obtained (Table 1). The concentration dependence
of k and V (Table 1) is probable as well as justifiable, since V, a parameter that is
related to the probabilty of finding a quencher molecule close enough to a newly
formed excited state molecule to quench it immediately, or statically, would
naturally decrease with concentration, k and V were also found to be pH-
dependent (Table 1). Although no regular pattern was observed for the dependence
of the quenching of daunomycin fluorescence on pH range 7-7.5, the significant
changes in the values of k could mean that either the donor-acceptor ability and
the interaction of the molecules in the ground state is changed by pH variation, or,
that the ground state daunomycin and quencher complexes are formed at pH ±7.5.
Quenching of Daunomycin Fluorescence by L-tryptophyl-L-tyrosine. The
Stern-Volmer plots of L-trp-L-tyr quenching of daunomycin fluorescence showed
neither negative nor positive deviations from linearity (figures not shown). Linear
Stern-Volmer plots (Eq. 8) are indicative of insignificant contributions of quenching
of fluorescence by static mechanism. At pH — 6.5, low values of kgy were
observed (Table 1). The observed insignifciant contributions to quenching of
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Stern-Volmer plot for the ATP quenching of daunomycin at daunomycin concentration of 1.35 x 10"5 M; the
sample was excited at 466 nm; pH 7.5; F and F are the fluorescence intensities (arbitrary units) in the absence
and presence of a quencher respectively.
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*5tudies at room temperature; fluorescence monitored at the emission Xmax
= 590 nm.
aL-tryptophyl-L-tryptophan; [daunomycin] = 1.35 x 10 M
bL-trytophyl-L-tyrosine; [daunomycin] = 1.30 x 10 M.
cAdenosine triphosphate; [daunomycin] = 1.30 x 10" M.
dAdenosine triphosphate; [daunomycin] = 1.35 x 10 M.
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the dependence of L-trp-L-tyr quenching of daunomycin fluorescence on pH, and an
overwhelming predominance of dynamic quenching mechanism.
Quenching of Myricetin Fluorescence by L-tryptophyl-L-tryptophan. Fig. 8
is representative of Stern-Volmer plots of L-trp-L-trp quenching of myricetin
fluorescence. Significant differences in the values of kgv and V were observed
(Table 2) with variation in solvents. In ethanol, and at Xex = 375 nm, kgv = 1265.25
M"1, V = 219 M"1. But in piperazine and NaCl buffer, and at the same excitation
wavelength - 375 nm, k = 109.29 M"1, V = 21.39 M"1 (Table 3). This dependence
of fluorescence quenching of myricetin on solvent may probably be due to factors
which include, but are not limited to, solvent polarity.
Enhancement of Daunomvcin Fluorescence by Myosin. Fig. 9 shows the plot
of 1/AF (F^ . - Fp. ) against 1/[myosin]. By extrapolating the curve to
Dm-myosm um °
zero concentration of myosin, F« was obtained. The monophasic behavior of the
curve is indicative of the presence of only one class of binding sites. With this
value of Foo, a log—log plot was constructed (Fig. 10). kd (dissociation constants)
value of 6.3 X 103 M"1 was obtained. The progressive enhancement (a dequenching
effect) produced by the progressive increase in the concentration of myosin is
probably due to the increasing unavailability of some group or groups for quenching
of one or more tryptophan residues in the complex. This probability is in line with
energy transfer processes.
Enhancement of Myricetin Fluoresence by DNA. Figs. 11 and 12 are plots for
the calculation of DNA enhancement parameters (pkd and kd) for myricetin






0 2.0 4.0 6.0
lQ] x 10"5 M
8.0 10.0 13.0
Fir. 8. Stern-Volmer plot for the L-tryptophyl-L-tryptophan quenching of myricetin; the sample was excited at
373 nm; solvent used is ethanol; F and F are the fluorescence
presence of a quencher (L-tryptophyl-L-tryptophan) respectively.
intensities (arbitrary units) in the absence and
Table 2. Scatchard Analysis of Deoxyribonucleic Acid Fluorescence Quenching of Daunomycin in the Presence and Absence



























































♦Studies at room temperature; [ Dm ] = 1.33 x 10" M; fluorescence intensity monitored at emission Xmax = 590 nm, and
the excitation X = 466 nm. Daunomycin is abbreviated as Dm; apparent association constant is abbreviated as k
(k - for intercalation mode of binding, k ,^. - for electrostatic binding mechanism); number of available ligands
appU) app1
(drug and drug + divalent metal ions) is abbreviated as L. kgv is the Stern-Volmer constant; V = static quenching constant; k
= intrinsic binding constant and is calculated as in Table 5; aan isolated potential binding site is assumed.
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Table 3. Quenching and Enhancement Parameters of Myricetin/
1 "d 2 1
Quencher k. (M"1) x 10."' V (M"1) \ v (nm) Solvent
L-trp-L-trpb 1265.28 — 219 375 ethanol
L-trp-L-trpb 109.29 — 21.39 375 H2OC
DNAd — 6.31 — 375 H00
a -5
Studies at room temperature; [myricetin] = 4.9 x 10" M; fluorescence













1/ [myosin] x 10" mg/ml
Fig. 9. Estimation of F» which is employed in the calculation of k . for the myosin enhancement of daunomycin
fluorescence in Fig. 10. Fluorescence data (enhancement) collected at emission X = 590 nm, excitation at
466 nm; solvent used is piperazine and NaCl; pH = 7.0; F and F are the fluorescence intensities (arbitrary units) in













-3.8 -3.7 -3.6 -3.5 -3.4 -3.3 -3.2 -3.1
-log [myosin]
Fig. 10. Estimation of k . for the myosin enhancement of daunornycin; Foo (fluorescence at saturation) estimated
from Fig. 9
respectively.















Fjr. 11. Estimation of F» which is employed in the calculation of kd for the deoxyribonucleic acid enhancement
of myricetin fluorescence in Fig. 12. Fluorescence data (enhancement) collected at emission X = 580 nm,
max
excitation at 375 nm; solvent used is piperazine and NaCl; pH = 7.0; F and F are the fluorescence intensities









-1.2 -1.0 -0.8 -0.6 -0.4 -0.2 0.0
-log [ DNA]
Fig. 12. Estimation of k. for the deoxyribonucleic acid enhancement of myricetin; F«> estimated from Fig. 11
was employed; F and F are the fluorescence intensities in the absence and presence of a quencher respectively.
F (intensity at infinite concentration of DNA) was obtained. With the F
00 00
obtained, a log—log plot was constructed (Fig. 12) from which k . (apparent
binding) was obtained. One class of binding sites was evident from the monophasic
behavior of the curve.
Quenching of Daunomycin Fluorescence by DNA in the Absence and Presence
of Divalent Metal Ions. Presented in Fig. 13 are the results of relative quenching
effects of DNA on daunomycin fluorescence, in the absence and presence of the
divalent metal ions Fe++, Cu++, Mg++, at different DNA/drug ratios. Fluorescence
intensity at saturation, F,,,, due to DNA in the absence of the divalent metal ions is
10%. The presence of the divalent metal ions resulted in a reduction of
fluorescence intensity, especially in the presence of Fe and Cu . The observed
F^ 's in the presence of Fe++, Cu++ and Mg++ are 2.2%, 3.2%, and 8.6%
respectively. The fluorescence intensities tend to level off at DNA/drug ratio of
1.2. The curvature of the Scatchard plots (Fig. 13-16) is indicative of a two site
binding model. The presence of the divalent metal ions did not effect any
significant change in the site model of the drug-DNA complex (Figs. 15-17). Figs.
18-21 show the Stern-Volmer and modified Stern-Volmer plots for the DNA
quenching of daunomycin fluorescence in the absence and presence of divalent
metal ions-Fe++, Cu++, Mg++. Table 3 presents the results of the analysis of
2k
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[DNA]/[Dm]
FjR. 13. Quenching effects of deoxyribonucleic acid on daunomycin fluorescence (excitation at 466 nm) in the
absence and presence of divalent metal ions. O= DNA; •= Mg++',/\= Cu++-,/^= Fe++; [ M +] /[Dm] = 1 M; M +
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Fig. 1^. Scatchard analysis of the quenching effect of deoxyribonucleic acid on the fluorescence of daunomycin.
The parameters r. (moles of ligand bound per nucleotide), and C (moles per liter of free ligand), were calculated
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Fig. 15. Scatchard analysis of the effect of Mg++ on the interactions between daunomycin and deoxyribonucleic
acid. The parameters r. (moles of ligand bound per nucleotide), and C (moles per liter of free ligands), were
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Fig. 16. Scatchard analysis of the effect of Cu++ on the interactions between daunomycin and deoxyribonucleic
acid. The parameters r. (moles of ligand bound per nucleotide), and C (moles per liter of free ligands), were
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Fig. 17. Scatchard analysis of the effect of Fe on the interactions between daunomycin and DNA. The
parameters r. (moles of ligand bound per nucleotide), and C (moles per liter of free ligands), were calculated by
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Fig. 18. Stern-Voimer plots for the deoxyribonucleic acid quenching of daunomycin; the sample was excited at 466
nm. F and F are the fluorescence intensities (arbitrary units) in the absence and presence of a quencher (DNA)






[Q] x 10"5 M
Fig. 19. Stern/Volmer plots for the deoxyribonucleic acid quenching of daunomycin-Mg++ complex; the sample
was excited at *66 nm; F and F are the fluorescence intensities (arbitrary units) in the absence and presence of a
quencher (DNA) respectively; Q = DNA; • = Stern-Volmer plot; O = modified Stern-Volmer plot; Mg /[ Dm] = 1; and













Fjr. 20. Stern-Volmer plots for the deoxyribonucleic acid quenching of daunomycin-Cu complex; the sample
was excited at 466 nm. F and F are the fluorescence intensities (arbitrary units) in the absence and presence of a
o
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[Q] x 10~5 M
Fig. 21. Stern-Volmer plots for the deoxyribonucleic acid quenching of daunomycin-Fe complex; the sample was
excited at 466 nm. Fq and F are the fluorescence intensities (arbitrary units) in the absence and presence of a
quencher (DNA) respectively; Q = DNA;^= Stern-Volmer plot;O= modified Stern-Volmer plot.
k and V were calculated from the Stern-Volmer plot, and K was calculated as
shown in Table ^. The apparent association constant (KaDD)> the static quenching
constant (V), as well as the intrinsic binding constant (k) for daunomycin-DNA
binding increased in the presence of the divalent metal ions-Fe++, Cu++, Mg++
(Table *). Fe++, with K nw% = 1.02 X 105 M'1, V = 2.70 X 10* M"1, and k = 7A5 X
app
h 1
10 M , showed the greatest increase in the constants. The corresponding
if, -1
constants in the absence of the divalent metal ions are k „ = 2.18 X 10 M , V =
1.69 X 10* M"1, and k = 5.88 X 10* M"1. k of 2.18 X 10* M"1 for DNA is small
app
compared to that obtained by other methods. Hence the fluorescence method
may not be very accurate. Although no regular sequence was observed in the
change or variation of the number of available binding sites per drug molecules, n^,
the presence of the divalent metal ions decreased the number of available binding
sites per drug molecule (fairly insignificant), thereby increasing the number of drug
molecules per site, Lj, when the mode of binding is intercalative. When the mode
of binding changed from intercalation to electrostatic binding, via the negative
phosphate ions of the DNA and the cationic daunomycin molecule, there was an
irregular, yet, a significant difference in the values of the number of available
binding sites per drug molecule, n2, and the number of drug molecules per site, L2,
in the presence of Fe++ and Cu++. This difference in the values of n2 and L2 for
Fe++ and Cu++ may suggest that n2 and L2 could not be determined with any
reasonable accuracy.
In both cases (in the absence and presence of divalent metal ions), the
primary mode of quenching is static (Figs. 18-21). Quenching by the collisional
mode is essentially insignificant as depicted by the values of the Stern-Volmer
45





























♦The intrinsic binding constant, K, is calculated from the equation
K = rb /c b ; r. = moles of drug bound per nucieotide, c = concentration
<l"2rb)
of free drug; K calculated above is for the effect of Mg on the
daunomycin-DNA interactions.
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constants, k 's (Table 4). This is reasonable because the Iigand is expected to form
a ground state complex. The observed increasing trend in the static quenching
constant, V (Table 4), is in agreement with the increasing trends of the apparent
association constant (KDD)* and the intrinsic binding constant, k. In this case, it is
reasonable to take V as an association constant, k. No particular trend was
observed, however, in the variations of K , the apparent association constant
app2
when the mode of binding is predominantly by electrostatics, an observation which
supports the fact that this mode of binding of daunomycin to DNA has not yet been
as fully established as the competing intercalative mode. This is the first time that




From the values of the collisional quenching constants (kgv) for the
fluorescence quenching of daunomycin observed, it is justifiable, to conclude that
ATP, L-tryptophyl-L-tryptophan, and L-tryptophyl-L-tyrosine are good quenchers.
It is even more justifiable to establish that DNA and L-tryptophy-L-tyrosine, are
also good quenchers especially for the fluorescence quenching of myricetin. The
increase in the apparent association constants for the daunomycin-DNA interaction
produced by the addition of the divalent metal ions suggests that these metal ions
interact with either daunomycin or DNA to enhance the formation of the
daunomycin-DNA complex. The metal ions possibly exert their effect by the
formation of a ternary metal-drug-DNA complex. Results from this research also
confirms that drug-macromolecular interaction is pH-dependent.
Since drug effects, of daunomycin in particular, are governed by factors
which include, but are not limited to, acceptor membrane permeability, pH of the
medium, pK , and effectiveness of binding, it may be of pharmacological interest
to study the relationship between daunomycin residency time when daunomycin is
administered alone, and when it is administered along with the quenchers studied,
Fe++, Cu++, and Mg++. If possibly the daunomycin residency time is reduced by the
addition of metal ions such as Fe++, Cu++, and Mg++, then we may in fact be
making progress toward possible elimination of the cardiotoxicity associated with
daunomycin.
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